{
    "id": 18830,
    "cites": 71,
    "cited_by": 3,
    "reference": [
        "Almasi, E.A., Stafford, R.S., Kravitz, R.L., and Mansfield, P.R. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093What are the public health effects of direct-to-consumer advertising?,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d PLoS Medicine, 3(3):e145, 2006.",
        "Avery, R.J., Kenkel, D., Lillard, D., Mathios, A., and Wang, H. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Health disparities and direct-to-consumer advertising of pharmaceutical products\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d, in: Lorens Helmchen, Robert Kaestner, Anthony Lo Sasso (eds.): Advances in Health Economics and Health Services Research 19:71-94, 2008.",
        "Bagwell, K. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Economic Analysis of Advertising,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d in M. Armstrong and R. Porter, eds., Handbook of Industrial Organization, Volume III (Amsterdam: North-Holland, 2007).",
        "Becker, G.S. and Murphy, K.M. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093A simple theory of advertising as a good or bad,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Quarterly Journal of Economics, 108:941\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c964, 1993.",
        "Berndt, E.R. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The United States experience with direct-to-consumer advertising of prescription drugs: what have we learned?\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d in: F.A. Sloan and C.R. Hsieh, eds., Promoting and Coping with Pharmaceutical Innovation: An International Perspective, (New York: Cambridge University Press, 2006).",
        "Berndt, E., Danzon, P.M., and Kruse, G.B. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Dynamic competition in pharmaceuticals: crossnational evidence from drug diffusion,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Managerial and Decision Economics, 28: 231250, 2007.",
        "Bhattacharya, J. and Vogt, G. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093A Simple Model of Pharmaceutical Price Dynamics,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Journal of Law and Economics, 46(2):599\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c626, 2003.",
        "Borden, N.H. The Economic Effects of Advertising. (Chicago: Richard D. Irwin, Inc., 1942).",
        "Bradford, W.D., Kleit, A.N., Nietert, P.J., et al. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093How direct-to-consumer television advertising for osteoarthritis drugs affect physicians\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 prescribing behavior,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Affairs, 25(5):1371-1377, 2006a.",
        "Bradford, W.D., Kleit, A.N., Nietert, P.J., et al. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Effects of Direct-to-Consumer Advertising of Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors on Attainment of LDL-C Goals,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Clinical Therapaeutics, 28(12):2105-2118, 2006b.",
        "Brekke, K.R., and Kuhn, M. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Direct to consumer advertising in pharmaceutical markets,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Health Economics, 25:102-30, 2006.",
        "Bulik, B.S. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Pharmaceutical Marketing,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Ad Age Insights White Paper, October 17 2011.",
        "Calfee, J.E., Winston, C., and Stempski, R. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Direct-to-Consumer advertising and the demand for cholesterol reducing drugs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Law and Economics, 45:673-90, 2002.",
        "Capella, M.L., Taylor, C.R., Campbell, R.C., and Longwell, L.S.\u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Do pharmaceutical marketing activities raise prices? evidence from five major therapeutic classes,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Public Policy & Marketing,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d 28(2), 146-61, 2009.",
        "Cawley, John; Rosemary Avery; and Matthew Eisenberg. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Effect of Advertising and Deceptive Advertising on Consumption: the Case of Over-the-Counter Weight Loss Products.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Working Paper, Cornell University, 2011.",
        "Chamberlin, E. The Theory of Monopolistic Competition. (Cambridge, MA: Harvard Univ. Press, 1933). Chintagunta, P.K., and Desiraju, R. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Strategic pricing and detailing behavior in international markets,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Marketing Science, 24(1): 67-80.",
        "Coney, S. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Direct-to-consumer advertising of prescription pharmaceuticals: a consumer perspective from New Zealand,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Public Policy and Marketing, 21(2): 213223, 2002.",
        "Darby, M.R. and Karni, E. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Free Competition and the Optimal Amount of Fraud,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Law and Economics, 16(1): 67-88, 1973.",
        "Dave, D. and Saffer, H. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Impact of direct-to-consumer advertising on pharmaceutical prices and demand,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Southern Economic Journal, 79(1): 97-126, 2012.",
        "David, G., Markowitz, S., and Richards-Shubik, S. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Economic Journal: Economic Policy, 2(4):1-25, 2010.",
        "Donohue, J.M., Berndt, E.R., Rosenthal, M., Epstein, A.M., and Frank, R.G. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Med Care, 42(12):1176-85, 2004.",
        "Dorfman, R., and Steiner, P.O. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Optimal advertising and optimal quality,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Economic Review, 44:826\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c836, 1954.",
        "Ellison, G., and Ellison, S.F. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Strategic entry deterrence and the behavior of pharmaceutical incumbents prior to patent expiration,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Economic Journal: Microeconomics, 3:1-36, 2011.",
        "Encinosa, W., Meyerhoefer, C., Zuvekas, S., and Du, D. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The inverse relationship between direct-to-consumer advertising and retail drug prices,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Working Paper, January 5, 2011.",
        "Erdem, T., Keane, M., and Sun, B. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The impact of advertising on consumer price sensitivity in experience goods markets,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Quantitative Marketing and Economics, 6:139-76, 2008.",
        "Frank, R.G., Berndt, E.R., Donohue, J.M., Epstein, A., and Rosenthal, M., Trends in direct-toconsumer advertising of prescription drugs. Kaiser Family Foundation (February 2002).",
        "http://www.kff.org/rxdrugs/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=1 General Accounting Office, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Prescription drugs: FDA oversight of direct-to-consumer advertising has limitations,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Report to Congressional Reporters (Washington, D.C.: U.S. General Accounting Office, 2002).",
        "Gonul, F., Carter, F., Petrova, E., and Srinivasan, K. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Promotion of prescription drugs and its impact on physicians\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 choice behavior,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Marketing, 65(3): 79-90, 2001.",
        "Hollon, M.F. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Direct-to-consumer advertising,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Journal of the American Medical Association, 293:2030-3, 2005.",
        "Hurwitz, M., and Caves, R. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Persuasion or information? promotion and the shares of brand name and generic pharmaceuticals,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Law and Economics, 31:299-320, 1988.",
        "Iizuka, T. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093What explains the use of direct to consumer advertising of prescription drugs?,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Industrial Economics, 52(3):349-379, 2004.",
        "Iizuka, T., and Jin, G.Z. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Effect of Prescription Drug Advertising on Doctor Visits,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Economics and Management Strategy, 14 (3):701-727, 2005.",
        "Iizuka, T., and Jin, G.Z. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Direct to Consumer Advertising and Prescription Choice,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Industrial Economics, 55 (4):771, 2007.",
        "Iwasaki, N., Kudo, Y., Tremblay, C.H., and Tremblay, V. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The advertising-price relationship: Theory and evidence,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d International Journal of the Economics of Business, 15:149-67, 2008.",
        "Kaldor, N.V. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The economic aspects of advertising,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Review of Economic Studies, 18:1\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c27, 1950.",
        "Kalyanaram, G. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Order of Entry Effect in Prescription (Rx) and Over-the-counter (OTC) Pharmaceutical Drugs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d International Journal of Pharmaceutical and Healthcare Marketing, 2(1):35-46, 2008.",
        "Kalyanaram, G. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Endogenous Modeling of the Effect of Direct Advertising to Consumers (DTCA) in Prescription Drugs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d International Journal of Pharmaceutical and Healthcare Marketing, 3(2): 137-148, 2009.",
        "K\u00c3\u0083\u00c2\u00b6nigbauer, I. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Advertising and generic market entry,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Health Economics, 26:286306, 2007.",
        "Kopp S.W., and Sheffet M.J. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The effect of direct-to-consumer advertising of prescription drugs on retail gross margins: empirical evidence and public policy implications\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d, Journal of Public Policy and Marketing, 16(2), 270-276, 1997.",
        "Kravitz, R.L., Epstein, R.M., Feldman, M.D., Franz, C.E., et al. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Influence of patients\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 requests for direct-to-consumer advertised antidepressants: a randomized controlled trial,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of the American Medical Association, 293(16), 1995-2002, 2005. Erratum in: JAMA 294 (19), 2436.",
        "Kwong, W.J. and Norton, E.C. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Effect of Advertising on Pharmaceutical Promotion,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Review of Industrial Organization, 31:221-236, 2007.",
        "Law, M.R., Majumdar, S.R., and Soumerai, S.B. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d British Medical Journal, 337:a1055, 2008.",
        "Law, M.R., Soumerai, S.B., Adams, A.S., and Majumdar, S.R. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Costs and Consequences of Direct-to-Consumer Advertising for Clopidogrel in Medicaid,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Archives of Internal Medicine, 169(21), 1969-74, 2009.",
        "Leffler, K.B. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Persuasion or information? the economics of prescription drug advertising,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Law and Economics, 24(1): 45-74, 1981.",
        "Lichtenberg, F.R., and Virabhak, S. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093 Pharmaceutical-embodied technical progress, longevity, and quality of life: Drugs as \u00c3\u00a2\u00e2\u0082\u00ac\u00cb\u009cequipment for your health\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2?\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Managerial and Decision Economics, 28:371-92, 2007.",
        "Ling, D.C., Berndt, E.R., and Kyle, M.K. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Deregulating Direct-to-Consumer marketing of prescription drugs: Effects on prescription and over-the-counter product sales,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Law and Economics, 45:691-723, 2002.",
        "Liu, Q., and Gupta, S. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The impact of direct-to-consumer advertising of prescription drugs on physician visits and drug requests: empirical findings and public policy implications,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d International Journal of Research in Marketing, 28:205-217, 2011.",
        "Manchanda and Chintagunta. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Responsiveness of Physician Prescription Behavior to Salesforce Effort: An Individual Level Analysis,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Marketing Letters, 15(2/3):129-145, 2004.",
        "Meyerhoefer, C.D., and Zuvekas, S.H. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The shape of demand: what does it tell us about directto -consumer marketing of antidepressants?,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The B.E. Journal of Economic Policy and Analysis, 8(2):Article 4, 2008.",
        "Mintzes, B., Morgan, S., and Wright, J.M. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Twelve years\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d PLoS One, 4(5)e5699:1-7, 2009.",
        "Mintzes, B., Barer, M.L., Kravitz, R.L., Bassett, K., Lexchin, J., Kazanjian, A., Evans, R.G., Pan, R., and Marion, S.A. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Canadian Medical Association Journal, 169:405-12, 52 Narayanan, S., Desiraju, R., and Chintagunta, P. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Return on investment implications for pharmaceutical promotional expenditures: the role of marketing-mix interactions,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Marketing, 68(4): 90-105, 2004.",
        "Narayanan, S., Manchanda, P., and Chintagunta, P. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Temporal differences in the role of marketing communication in new product categories,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Marketing Research, 42: 278-290, 2005.",
        "Nelson, P. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Information and consumer behavior,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Political Economy, 78:311\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c329, 1970.",
        "Nelson, P. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Advertising as information,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Political Economy, 82:729\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c754, 1974.",
        "Ozga, S.A. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Imperfect markets through lack of knowledge,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Quarterly Journal of Economics, 74:29\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c52, 1960.",
        "Posner, R. Regulation and Advertising by the FTC (Washington D.C.: American Enterprise Institute, 1973).",
        "Rizzo, J. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Advertising and Competition in the Ethical Pharmaceutical Industry: The case of Hypertensive Drugs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Law and Economics, 42(1),89-116, 1999.",
        "Robinson, J. Economics of Imperfect Competition. (London: MacMillan and Co., 1933).",
        "Rosenthal, M.B., Berndt, E.R, Donohue, J.M., Epstein, A.M., and Frank, R.G. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Demand effects of recent changes in prescription drug promotion,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d in Frontiers in health policy research, volume 6, edited by David M. Cutler and Alan M. Garber. Cambridge, MA: MIT Press, pp. 1-26, 2003.",
        "Scott Morton, F.M. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Barriers to entry, brand advertising, and generic entry in the U.S. pharmaceutical industry,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d International Journal of Industrial Organization, 18:1085\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 1104, 2000.",
        "SK&A. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u00932010 U.S. Pharma Company Promotion Spending,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Cegedim Strategic Data Report, http://www.skainfo.com/, January 2011.",
        "SK&A. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u00932011 U.S. Pharma Company Promotion Spending,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Cegedim Strategic Data Report, http://www.skainfo.com/, February 2012.",
        "Steiner, R. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Does advertising lower consumer prices?,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Marketing, 37(4):19-26, 1973.",
        "Steiner, R. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The inverse association between margins of manufacturers and retailers,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Review of Industrial Organization, 8:717-740, 1993.",
        "Stigler, G.J. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The economics of information,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Political Economy, 69:213\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c225, 1961.",
        "Stigler, G.J. and Becker, G.S. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093De gustibus non est disputandum,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Economic Review, 67:76\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c90, 1977.",
        "Tentler, A., Silberman, J., Paterniti, D., Kravitz, R., and Epstein, R. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Factors affecting physicians\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 responses to patients\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 requests for antidepressants: Focus group study,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of General Internal Medicine, 23:51-7, 2008.",
        "Toop, L., and Mangin, D. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Industry funded patient information the slippery slope to New Zealand,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d British Medical Journal, 335(7622): 694-695, 2007. Toop, L., Richards, D., Dowell, T., Tilyard, M., Fraser, T., and Arroll, B. Direct to consumer advertising of prescription drugs in New Zealand: for health or for profit? Report to the Minister of Health supporting the case for a ban on DTCA. New Zealand departments of general practice. Christchurch, Dunedin, Wellington and Auckland Schools of Medicine.",
        "Verma, V.K. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093A price theoretic approach to the specification and estimation of the salesadvertising function,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Business, 53:S115\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009cS137, 1980.",
        "Wax, P.M. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Elixirs, diluents, and the passage of the 1938 federal food, drug, and cosmetic act,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Annals of Internal Medicine, 122(6):456-461, 1995.",
        "Wilkes, M.S., Bell, R.A., and Kravitz, R.L. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Direct-to-consumer prescription drug advertising: Trends, impact, and implications,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Affairs, 19:110-28, 2000. Wosi\u00c3\u0085\u00e2\u0080\u009eska, M. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Just what the patient ordered? Direct-to-consumer advertising and the demand for pharmaceutical products,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Harvard Business School Marketing Research Papers No. 0204,"
    ]
}